CRP was first isolated in 1930 from plasma of patients with pneumococcal pneumonia. It was named because it binds to the C-polysaccharide of Streptococcus pneumoniae. It belongs to the pentraxin family - a 115 kDa pentamer of five non-covalently linked 23 kDa subunits arranged in cyclic symmetry. With Ca²⁺ ions, it binds phosphocholine, phospholipids, fibronectin, chromatin, and histones - all exposed at sites of tissue damage. This structure has been highly conserved over hundreds of millions of years of evolution. - Firestein & Kelley's Textbook of Rheumatology
-
Produced primarily by hepatocytes, stimulated by cytokines - chiefly interleukin-6
-
Rises within 6-12 hours of the initial inflammatory insult
-
Peaks at 2-3 days, reflecting the extent of tissue injury
-
Half-life ~19 hours - drops rapidly once the stimulus is removed
-
Levels may be affected by underlying liver dysfunction (single-organ origin)
-
Persistent elevations are seen in chronic inflammatory/infectious states (e.g., active RA, pulmonary TB) and extensive malignancy
-
Tietz Textbook of Laboratory Medicine, 7th Edition & Firestein & Kelley's Textbook of Rheumatology
-
Promotes non-inflammatory clearance of apoptotic cells
-
Prevents neutrophil adhesion to the endothelium
-
Opsonizes particles for phagocytosis
-
Firestein & Kelley's Textbook of Rheumatology
-
Estimated pooled sensitivity 75%, specificity 67% for differentiating bacterial from non-bacterial inflammation
-
CRP >500 mg/L: bacterial infection present in ~88% of cases
-
Used to guide antibiotic therapy decisions (e.g., COPD exacerbations, bone & joint infections in children)
-
CRP-guided antibiotic discontinuation (discontinue at 75% reduction from peak): shown to be non-inferior to fixed 7- or 14-day courses in gram-negative bacteremia
-
CRP improves with appropriate antibiotic therapy; persistently elevated levels associated with poor outcomes
-
Tietz Textbook of Laboratory Medicine, 7th Edition
-
Higher baseline CRP is associated with increased risk of ASCVD and stroke
-
The Physicians' Health Study showed CRP averaged 1.51 mg/L in MI patients vs. 1.13 mg/L in controls
-
The 2019 ACC/AHA primary prevention guideline identifies CRP ≥2.0 mg/L as an "ASCVD risk enhancer" that may influence therapeutic decisions
-
Universal hs-CRP screening is not recommended
-
Most useful in patients with intermediate 10-year risk (10-20%) where additional information may guide therapy
-
Henry's Clinical Diagnosis and Management by Laboratory Methods